Sharon Bio-Medicine Ltd. announced earnings results for the third quarter ended December 31, 2020. For the third quarter, the company announced total revenue was INR 462.474 million compared to INR 399.765 million a year ago. Net income was INR 45.634 million compared to INR 15.873 million a year ago. For the nine months, total revenue was INR 1,263.199 million compared to INR 1,267.151 million a year ago. Net income was INR 84.369 million compared to net loss of INR 625.47 million a year ago.